SI
AGTC

Sofinnova Investments’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Sofinnova Investments’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-825,071
Closed -$4.01M – 85
2020
Q3 		$4.01M Sell
825,071
-320,183
-28% -$1.75M 0.3% 51
2020
Q2 		$6.34M Buy
1,145,254
+82,639
+8% +$378K 0.4% 47
2020
Q1 		$3.48M Buy
+1,062,615
New +$5.6M 0.32% 42

Other funds holding AGTC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sofinnova Investments's AGTC Position: Q4 2020 in Review

Sofinnova Investments sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2020, closing a stake of 825,071 shares — an estimated $4.01M sold.

Sofinnova Investments first reported a position in AGTC in Q1 2020 and held it in 3 quarters. The position peaked at $6.34M in Q2 2020. 66 funds tracked by Wall St. Rank hold AGTC as of Q4 2020.

  • Sofinnova Investments reported no remaining Applied Genetic Technologies Corporation position as of Q4 2020 after selling out during the quarter.
  • Sofinnova Investments sold 825,071 Applied Genetic Technologies Corporation shares in Q4 2020, an estimated $4.01M.
  • Sofinnova Investments first reported a position in Applied Genetic Technologies Corporation in Q1 2020 and held it in 3 quarters.
  • Sofinnova Investments's Applied Genetic Technologies Corporation position peaked at $6.34M in Q2 2020.
  • 66 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2020.

Based on Sofinnova Investments's 13F filing for Q4 2020, filed 16 Feb 2021.